Mode
Text Size
Log in / Sign up

Malignant left-sided colorectal obstruction

Part of Cancer

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Review of rectal abscess case after endoscopic mucosal resection highlights diagnostic considerations
Rheumatology Sys. Review
Review of rectal abscess case after endoscopic mucosal resection highlights diagnostic considerations Rectal Surgery Complication Doctors Rarely See But Must Spot Fast
This narrative review discusses a case of rectal submucosal abscess following endoscopic mucosal resection for a rectal polyp in a 74-year-o…
A 74-year-old woman developed a dangerous hidden infection after standard polyp removal, proving why doctors must recognize rare complicatio…
AI-Assisted Colonoscopy Improves Right-Sided Adenoma Detection in Gastroenterology Fellows
Gastroenterology RCT
AI-Assisted Colonoscopy Improves Right-Sided Adenoma Detection in Gastroenterology Fellows AI helps trainee doctors find more polyps in colonoscopies
This pragmatic randomized controlled trial assigned 16 gastroenterology fellows to AI-enhanced or conventional colonoscopy for 1045 procedur…
AI-assisted colonoscopy helped gastroenterology fellows detect more polyps on the right side of the colon, a hard-to-see area.
Neoadjuvant mFOLFOXIRI plus bevacizumab reduces peritoneal tumor burden in colorectal cancer patients
Oncology RCT
Neoadjuvant mFOLFOXIRI plus bevacizumab reduces peritoneal tumor burden in colorectal cancer patients Chemo before surgery may reduce tumor burden in colorectal cancer patients
This phase II randomized controlled trial evaluated 53 patients with resectable peritoneal metastasis of colorectal cancer.
A trial suggests chemo before surgery might lower tumor markers for colorectal cancer patients with spread to the abdomen.
Early-Onset Colorectal Cancer Shows Superior Survival vs Late-Onset in Retrospective Cohort
Geriatrics & Aging Cohort
Early-Onset Colorectal Cancer Shows Superior Survival vs Late-Onset in Retrospective Cohort Younger Colon Cancer Patients Live Longer After Surgery
A retrospective cohort study of 4,596 colorectal cancer patients found that early-onset disease (EOCRC) was associated with significantly be…
Even with tougher tumors, younger colon cancer patients are living longer after surgery than older patients, and doctors now have hard data …
Tumor debulking plus chemotherapy did not improve overall survival in multiorgan metastatic colorectal cancer patients
Oncology RCT
Tumor debulking plus chemotherapy did not improve overall survival in multiorgan metastatic colorectal cancer patients Surgery Doesn’t Extend Life for Advanced Colon Cancer
This randomized clinical trial enrolled 382 adult patients with multiorgan metastatic colorectal cancer across 27 hospitals in the Netherlan…
This large study shows that removing tumors in advanced colon cancer doesn’t help people live longer.
Global burden of early-onset colorectal cancer from alcohol, tobacco, and inactivity declined 1990-2021
Oncology Cohort
Global burden of early-onset colorectal cancer from alcohol, tobacco, and inactivity declined 1990-2021 More Young Adults Getting Colorectal Cancer — But One Risk Stands Out
This global cohort review analyzed early-onset colorectal cancer attributable to behavioral risk factors from 1990 to 2021.
While smoking and drinking risks drop, lack of physical activity is driving a sharp rise in colon cancer for adults under 50 worldwide.
Observational study suggests colibactin mutations are enriched in rectum regardless of polyp status
Genetics & Precision Medicine
Observational study suggests colibactin mutations are enriched in rectum regardless of polyp status Why do some colon cancers start in the rectum while others do not?
This observational study analyzed whole-genome sequencing of colon crypts from 11 donors without polyps and 10 with polyps.
A toxin from E. coli bacteria causes specific DNA damage in the rectum, which may explain why some colon cancers start there, especially in …
Robotic simultaneous resection for synchronous colorectal cancer and liver metastases shows feasibility and safety in a meta-analysis
Gastroenterology Meta-analysis
Robotic simultaneous resection for synchronous colorectal cancer and liver metastases shows feasibility and safety in a meta-analysis Robots Are Removing Colon Cancer and Liver Tumors in One Operation
This single-arm meta-analysis included 165 patients aged 18 or older with synchronous colorectal cancer and liver metastases.
Robotic surgery safely removes colon cancer and liver tumors in one operation, sparing some patients a second major procedure.
Phase I trial of regorafenib plus ipilimumab and nivolumab shows 27.6% response in MSS colorectal cancer
Gastroenterology Phase I
Phase I trial of regorafenib plus ipilimumab and nivolumab shows 27.6% response in MSS colorectal cancer Who Really Responds to a Stubborn Colon Cancer Combo?
A phase I trial in 29 patients with microsatellite-stable metastatic colorectal cancer tested the combination of regorafenib, ipilimumab, an…
A three-drug combo helped some patients with stubborn colon cancer, and immune markers now predict who will benefit most.
Self-expandable metal stents improve patency and survival in malignant hilar biliary obstruction
Palliative Care Meta-analysis
Self-expandable metal stents improve patency and survival in malignant hilar biliary obstruction Which stent helps people with blocked bile ducts live longer?
A meta-analysis of individual patient data from 5 RCTs (322 patients) found that self-expandable metal stents (SEMSs) significantly improved…
Metal stents help people with blocked bile ducts live longer and avoid repeat procedures compared to plastic tubes, according to new analysi…
Phase II RCT finds no OS benefit for hepatectomy in colorectal cancer with liver and lung metastases
Gastroenterology RCT
Phase II RCT finds no OS benefit for hepatectomy in colorectal cancer with liver and lung metastases Does removing liver tumors help when lung tumors remain? A small trial offers mixed answers
A phase II randomized trial in 27 patients with colorectal adenocarcinoma and resectable liver/unresectable lung metastases compared hepatec…
A small trial stopped early found no survival benefit for liver surgery when lung tumors remain, yet patients who actually got the operation…
Anti-EGFR rechallenge improves response and PFS but not OS in ctDNA wild-type chemorefractory mCRC
Gastroenterology Meta-analysis
Anti-EGFR rechallenge improves response and PFS but not OS in ctDNA wild-type chemorefractory mCRC Anti-EGFR rechallenge shows benefit for some advanced colorectal cancer patients
A meta-analysis of three phase II randomized trials (n=320) in pretreated ctDNA RAS/BRAF wild-type mCRC found anti-EGFR rechallenge signific…
Giving anti-EGFR drugs again helps some advanced colorectal cancer patients shrink tumors and delay growth, though it does not extend overal…